Close

Galapagos NV (GLPG): Filgotinib Progressing Nicely - Stifel

May 1, 2017 7:16 AM EDT Send to a Friend
Stifel analyst, Adam Walsh, reiterated his Hold rating on shares of Galapagos NV (NASDAQ: GLPG) but raised his price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login